252 related articles for article (PubMed ID: 9915548)
1. Recent advances in our understanding of Wiskott-Aldrich syndrome.
Sullivan KE
Curr Opin Hematol; 1999 Jan; 6(1):8-14. PubMed ID: 9915548
[TBL] [Abstract][Full Text] [Related]
2. The genotype of the original Wiskott phenotype.
Binder V; Albert MH; Kabus M; Bertone M; Meindl A; Belohradsky BH
N Engl J Med; 2006 Oct; 355(17):1790-3. PubMed ID: 17065640
[TBL] [Abstract][Full Text] [Related]
3. Wiskott-Aldrich syndrome: new molecular and biochemical insights.
Peacocke M; Siminovitch KA
J Am Acad Dermatol; 1992 Oct; 27(4):507-19. PubMed ID: 1401301
[TBL] [Abstract][Full Text] [Related]
4. The Wiskott-Aldrich syndrome.
Ochs HD
Springer Semin Immunopathol; 1998; 19(4):435-58. PubMed ID: 9618767
[No Abstract] [Full Text] [Related]
5. Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome.
Candotti F
J Clin Immunol; 2018 Jan; 38(1):13-27. PubMed ID: 29086100
[TBL] [Abstract][Full Text] [Related]
6. Current and emerging treatment options for Wiskott-Aldrich syndrome.
Worth AJ; Thrasher AJ
Expert Rev Clin Immunol; 2015; 11(9):1015-32. PubMed ID: 26159751
[TBL] [Abstract][Full Text] [Related]
7. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
[TBL] [Abstract][Full Text] [Related]
8. Wiskott-Aldrich syndrome.
Notarangelo LD; Miao CH; Ochs HD
Curr Opin Hematol; 2008 Jan; 15(1):30-6. PubMed ID: 18043243
[TBL] [Abstract][Full Text] [Related]
9. Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation.
Jin Y; Mazza C; Christie JR; Giliani S; Fiorini M; Mella P; Gandellini F; Stewart DM; Zhu Q; Nelson DL; Notarangelo LD; Ochs HD
Blood; 2004 Dec; 104(13):4010-9. PubMed ID: 15284122
[TBL] [Abstract][Full Text] [Related]
10. Wiskott-Aldrich Syndrome: a model for defective actin reorganization, cell trafficking and synapse formation.
Notarangelo LD; Ochs HD
Curr Opin Immunol; 2003 Oct; 15(5):585-91. PubMed ID: 14499269
[TBL] [Abstract][Full Text] [Related]
11. Linking cellular activation to cytoskeletal reorganization: Wiskott-Aldrich syndrome as a model.
Stewart DM; Tian L; Nelson DL
Curr Opin Allergy Clin Immunol; 2001 Dec; 1(6):525-33. PubMed ID: 11964736
[TBL] [Abstract][Full Text] [Related]
12. Wiskott-Aldrich syndrome in Argentina: 17 unique, including nine novel, mutations.
El-Hakeh J; Rosenzweig S; Oleastro M; Basack N; Berozdnik L; Molina F; Rivas EM; Zelazko M; Danielian S
Hum Mutat; 2002 Feb; 19(2):186-7. PubMed ID: 11793485
[TBL] [Abstract][Full Text] [Related]
13. [Clinical features and genotype analysis of 132 patients with Wiskott-Aldrich syndrome].
Li W; Liu D; Zhang X; Ding Y; Zhao X
Zhonghua Er Ke Za Zhi; 2015 Dec; 53(12):925-30. PubMed ID: 26887548
[TBL] [Abstract][Full Text] [Related]
14. Genetic and clinical advances in Wiskott-Aldrich syndrome.
Sullivan KE
Curr Opin Pediatr; 1995 Dec; 7(6):683-7. PubMed ID: 8776019
[TBL] [Abstract][Full Text] [Related]
15. Wiskott-Aldrich syndrome/X-linked thrombocytopenia in China: Clinical characteristic and genotype-phenotype correlation.
Liu DW; Zhang ZY; Zhao Q; Jiang LP; Liu W; Tu WW; Song WX; Zhao XD
Pediatr Blood Cancer; 2015 Sep; 62(9):1601-8. PubMed ID: 25931402
[TBL] [Abstract][Full Text] [Related]
16. [Wiskott-Aldrich syndrome].
Gulácsy V; Maródi L
Orv Hetil; 2008 Jul; 149(29):1367-71. PubMed ID: 18617469
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the Wiskott-Aldrich syndrome protein and its role in the disease.
Nonoyama S; Ochs HD
Curr Opin Immunol; 1998 Aug; 10(4):407-12. PubMed ID: 9722916
[TBL] [Abstract][Full Text] [Related]
18. Clinical, Laboratory Features and Clinical Courses of Patients with Wiskott Aldrich Syndrome and X-linked Thrombocytopenia-A single center study.
Bildik HN; Cagdas D; Ozturk Kura A; Oskay Halacli S; Sanal O; Tezcan I
Immunol Invest; 2022 Jul; 51(5):1272-1283. PubMed ID: 34098853
[TBL] [Abstract][Full Text] [Related]
19. Molecular biology of the Wiskott-Aldrich syndrome.
Rengan R; Ochs HD
Rev Immunogenet; 2000; 2(2):243-55. PubMed ID: 11258421
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for the Wiskott-Aldrich syndrome.
Galy A; Thrasher AJ
Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):545-50. PubMed ID: 21971332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]